Skip to Main Content

Author Details

Anne Haegert
University of British Columbia
2008
35
19
PMIDPaper TitleJournal TitlePublished Year
36181708Indwelling stents cause obstruction and induce ureteral injury and fibrosis in a porcine model.BJU Int2023
37556934Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.Gynecol Oncol2023
36895072Differentiation of Peritubular Myoid-Like Cells from Human Induced Pluripotent Stem Cells.Adv Biol (Weinh)2023
35082166Modeling Androgen Deprivation Therapy-Induced Prostate Cancer Dormancy and Its Clinical Implications.Mol Cancer Res2022
35816165Isolating Nuclei From Frozen Human Heart Tissue for Single-Nucleus RNA Sequencing.Curr Protoc2022
33038264GRB10 sustains AR activity by interacting with PP2A in prostate cancer cells.Int J Cancer2021
33506972Perivascular lymphocytic aggregates in hip prosthesis-associated adverse local tissue reactions demonstrate Th1 and Th2 activity and exhausted CD8<sup>+</sup> cell responses.J Orthop Res2021
34381166Ketogenesis controls mitochondrial gene expression and rescues mitochondrial bioenergetics after cervical spinal cord injury in rats.Sci Rep2021
34192572Cobalt ions induce metabolic stress in synovial fibroblasts and secretion of cytokines/chemokines that may be diagnostic markers for adverse local tissue reactions to hip implants.Acta Biomater2021
33945683Novel Lignin-Capped Silver Nanoparticles against Multidrug-Resistant Bacteria.ACS Appl Mater Interfaces2021
33441310Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.Cancer Res2021
32512818Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development.Cells2020
29487201Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.Cancer Res2018
28330676Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer.Eur Urol2018
29544736Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.Eur Urol2018
27531099SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.Bioinformatics2017
28259916Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis.Mol Med Rep2017
28460430Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.Oncotarget2017
28642484miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer.Sci Rep2017
27663589<i>BIRC6</i> Targeting as Potential Therapy for Advanced, Enzalutamide-Resistant Prostate Cancer.Clin Cancer Res2017
27015368The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells.Oncotarget2016
27148695Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer.JAMA Oncol2016
25544761Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer.Oncotarget2015
26235627The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.Cell Rep2015
26041878Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies.Oncotarget2015
25712683Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.Clin Cancer Res2015
24356420High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development.Cancer Res2014
25155515Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer.Genome Biol2014
22294438Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer.J Pathol2012
22553170From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.J Pathol2012
22615732Deficiency in nucleotide excision repair family gene activity, especially ERCC3, is associated with non-pigmented hair fiber growth.PLoS One2012
22252602Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.Mol Cancer Ther2012
19932600Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray.J Dermatol Sci2010
19168852Germline CDH1 deletions in hereditary diffuse gastric cancer families.Hum Mol Genet2009
18200053Superficial, nodular, and morpheiform basal-cell carcinomas exhibit distinct gene expression profiles.J Invest Dermatol2008
  • 1 - 35 of 35

Recommended Authors

Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 9
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 9
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 9
Oncology R&D
Career Start Year 2013
Number of shared co-authors 9
University of Colorado Denver | Anschutz Medical Campus
Career Start Year 2013
Number of shared co-authors 0
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 15
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 15
University of California-San Francisco
Career Start Year 2008
Number of shared co-authors 23
Institute for Pathology, University Hospital Schleswig-Holstein
Career Start Year 2007
Number of shared co-authors 10
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 5
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 1
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 27
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Career Start Year 2003
Number of shared co-authors 8
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 18
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 30
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 8
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 24
Research Institute of the McGill University Health Centre
Career Start Year 2000
Number of shared co-authors 8
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 29
University College London
Career Start Year 1999
Number of shared co-authors 5
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 17
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 10
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 18
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 34
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 9
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 6
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 9
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 18
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 24

Collaborators

University of British Columbia
Co-authored papers 24
University of British Columbia
Co-authored papers 19
University of British Columbia
Co-authored papers 18
University of British Columbia
Co-authored papers 15
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 15
Fujian Medical University Cancer Hospital and Fujian Cancer Hospital
Co-authored papers 12
University of British Columbia
Co-authored papers 11
University of British Columbia
Co-authored papers 10
University of British Columbia
Co-authored papers 10
Institute of Stem Cell and Regeneration, Chinese Academy of Sciences
Co-authored papers 9
University of British Columbia
Co-authored papers 9
University of British Columbia
Co-authored papers 9
University of British Columbia
Co-authored papers 7
University of British Columbia
Co-authored papers 6
University of British Columbia
Co-authored papers 5
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
University of British Columbia
Co-authored papers 5
Contextual Genomics Inc.
Co-authored papers 4
University of Michigan Medical School.
Co-authored papers 4
Dana-Farber Cancer Institute
Co-authored papers 4
National Cancer Institute, National Institutes of Health
Co-authored papers 4
University of Bern
Co-authored papers 4
University of British Columbia
Co-authored papers 4
University of California San Francisco
Co-authored papers 3
University of British Columbia
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Washington University in St Louis
Co-authored papers 3
University of British Columbia
Co-authored papers 3
University of British Columbia
Co-authored papers 3
Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University
Co-authored papers 3